Anika Therapeutics, Inc. (ANIK) Q2 2025 Earnings Call Transcript — Neutral
ANIK Seeking Alpha — July 30, 2025Anika Therapeutics, Inc. (NASDAQ:ANIK ) Q2 2025 Earnings Conference Call July 30, 2025 8:30 AM ET Company Participants Cheryl Renee Blanchard - President, CEO & Director Matt Hall - Corporate Participant Stephen D. Griffin - Executive VP, CFO & COO Conference Call Participants Anderson Schock - B.
AXIS Capital Q2 Earnings Surpass Estimates, Premiums Increase Y/Y — Positive
AXS Zacks Investment Research — July 30, 2025AXS' Q2 results reflect improved underwriting income across both segments, higher net premiums earned, offset by higher expenses.
Is the Options Market Predicting a Spike in InfuSystems Holdings Stock? — Neutral
INFU Zacks Investment Research — July 30, 2025Investors need to pay close attention to InfuSystems Holdings stock based on the movements in the options market lately.
WEX Stock Rallies 6.5% Since Q2 Earnings & Revenue Beat — Positive
WEX Zacks Investment Research — July 30, 2025WEX tops Q2 earnings and revenue estimates, lifts guidance and gains 6.5% post-earnings as the Benefits segment offsets declines in Mobility and Payments.
Here's Why Artisan Partners Asset Management (APAM) is a Strong Momentum Stock — Positive
APAM Zacks Investment Research — July 30, 2025Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Amphenol (APH) is a Strong Momentum Stock — Positive
APH Zacks Investment Research — July 30, 2025The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Affiliated Managers Group (AMG) is a Top Momentum Stock for the Long-Term — Positive
AMG Zacks Investment Research — July 30, 2025Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why MPLX LP (MPLX) is a Top Momentum Stock for the Long-Term — Positive
MPLX Zacks Investment Research — July 30, 2025Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why ArcelorMittal (MT) is a Strong Momentum Stock — Positive
MT Zacks Investment Research — July 30, 2025Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Qualcomm (QCOM) is a Top Momentum Stock for the Long-Term — Positive
QCOM Zacks Investment Research — July 30, 2025Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Regions Financial (RF) is a Strong Momentum Stock — Positive
RF Zacks Investment Research — July 30, 2025The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
GSK may have numbers may have been flattered by order timing, says bank — Neutral
GSK Proactive Investors — July 30, 2025GSK PLC (LSE:GSK, NYSE:GSK) delivered a strong set of second-quarter results, beating expectations on sales, profits, and earnings per share, and raised its guidance to the top end of its previous range. However, UBS analysts caution that much of this outperformance was driven by timing effects, such as early HIV medicine orders and stock builds, particularly in France for the Shingrix vaccine, which are likely to reverse later in the year.
Luxfer Holdings PLC (LXFR) Q2 2025 Earnings Call Transcript — Neutral
LXFR Seeking Alpha — July 30, 2025Luxfer Holdings PLC (NYSE:LXFR ) Q2 2025 Earnings Conference Call July 30, 2025 8:30 AM ET Company Participants Andrew William John Butcher - CEO & Executive Director Kevin Cornelius Grant - Vice President of Investor Relations & Business Development Stephen M. D. Webster - Chief Financial Officer Conference Call Participants Stephen Michael Ferazani - Sidoti & Company, LLC Operator Good morning.
Wall Street is reportedly growing impatient with the pace of Apple's artificial intelligence efforts. Apple has not been transparent about its strategy, while its competitors have announced plans for new AI-centered data centers and devices, CNBC reported Wednesday (July 30).
Amazon's artificial intelligence licensing deal with The New York Times reportedly carries an eight-figure annual price tag. The tech giant will pay the news company between $20 million and $25 million per year for content to train its AI models, The Wall Street Journal (WSJ) reported Wednesday (July 30), citing unnamed sources.
Wingstop Shares Soar on Robust Q2 Performance, Higher Growth Projections — Positive
WING Investopedia — July 30, 2025Shares of Wingstop (WING) surged more than 25% Wednesday after the chicken chain posted better-than-expected second-quarter results and raised its global unit growth outlook.
Humana Boosts Outlook on Lower-Than-Expected Medicare Advantage Membership Drop — Positive
HUM Investopedia — July 30, 2025Humana (HUM) shares took off Wednesday when the health insurer boosted its guidance as it sees fewer losses of Medicare Advantage customers than previously thought.
Dutch court says diesel brands now owned by Stellantis had cheating software from 2009 — Negative
STLA Reuters — July 30, 2025A Dutch court on Wednesday said diesel cars sold by Opel, Peugeot, Citroen and DS in the Netherlands from 2009 contained software designed to cheat emissions tests.
W.P. Carey's FFO Surpasses Estimates in Q2, Revenues Grow Y/Y — Positive
WPC Zacks Investment Research — July 30, 2025WPC beats Q2 AFFO estimates with strong investment gains, lifts 2025 outlook on robust rent growth and asset sales.
3 Genomics Stocks Worth Adding to Your Portfolio in 2025 — Neutral
EDIT NTLA PRME Zacks Investment Research — July 30, 2025An updated edition of the June 27, 2025, article.
